Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Mallinckrodt
Merck
Medtronic
AstraZeneca

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

EVEX Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Evex, and what generic alternatives are available?

Evex is a drug marketed by Roche Palo and is included in two NDAs.

The generic ingredient in EVEX is estrogens, esterified. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the estrogens, esterified profile page.

Summary for EVEX
Drug patent expirations by year for EVEX
Synonyms for EVEX
[(1S,10R,11S,15S)-15-methyl-14-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-5-yl]oxidanesulfonic acid
[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate
[3H]-estrone hydrogen sulfate
[3H]-estrone-3-sulphate
[3H]estrone-3-sulfate
[3H]estrone-3-sulphate
1,3,5(10)-Estratrien-17-one 3-sulfate
1,3,5(10)-ESTRATRIEN-3-OL-17-ONE 3-SULFATE POTASSIUM
1,3,5(10)-ESTRATRIEN-3-OL-17-ONE SULPHATE, SODIUM SALT
1240-04-6 (potassium salt)
17-oxoestra-1,3,5(10)-trien-3-yl hydrogen sulfate
17-Oxoestra-1,3,5(10)-trien-3-yl sodium sulfate
17-oxoestra-1,3,5(10)-trien-3-yl sulfate
3-(Sulfonatooxy)estra-1,3,5(10)-triene-17-one
3-Hydroxyestra-1,3,5(10)-trien-17-one hydrogen sulphate
438-67-5
438-67-5 (hydrochloride salt)
481-97-0
481-97-0 (Parent)
6K6FDA543A
AB00514744
AC1MHDJ1
AC1NS0NL
AC1Q1VL0
AKOS015967195
AN-23448
API0000550
BDBM38034
BDBM50366524
BPBio1_000897
BRD-K51095933-231-03-2
BSPBio_000815
C-53154
C02538
CCG-101163
CCRIS 9319
CHEBI:17474
CHEBI:60050
CHEBI:8389
CHEMBL2106240
CHEMBL494753
cid_23674502
Conestoral
Conjugated estrogens: sodium estrone sulfate
CTK4I7843
CTK7H2771
D00312
DB04574
EINECS 207-120-4
EINECS 207-575-9
Estra-1,3,5 (10)-triene-17-one-3-yl-sulfate
Estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, sodium salt
Estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, sodium salt (9CI)
Estra-1,3,5(10)-trien-17-one,3-(sulfooxy)-, sodium salt (1:1)
Estra-1,5(10)-trien-17-one, 3-(sulfooxy)-, sodium salt
Estra-1(10),2,4-trien-17-one, 3-(sulfooxy)-
Estrogenic substances
Estrogenic substances (conjugated)
Estrogens
estron-3-sulfate
Estrone hydrogen sulfate
Estrone hydrogen sulphate
Estrone 3-sulfate
estrone 3-sulfate anion
Estrone 3-sulfate sodium salt
estrone 3-sulfate(1-)
Estrone 3-sulphate
Estrone bisulfate
Estrone estrone hydrogen sulfate
Estrone hemisulfate
Estrone hydrogen sulfate
estrone hydrogen sulphate
ESTRONE SODIUM SULFATE
Estrone Sodium Sulfate [USAN]
Estrone sodium sulphate
Estrone sulfate
Estrone sulfate sodium
Estrone sulfate sodium salt
Estrone sulphate
Estrone sulphate sodium
estrone-3-sulfate
Estrone-3-sulfate sodium salt
estrone-3-sulphate
estrone-sulfate
Estrone, hydrogen sulfate
Estrone, hydrogen sulfate sodium salt
Estrone, hydrogen sulfate, sodium salt
Estropipate (USP)
GTPL4748
GTPL4749
HMS2052J05
HMS2232J23
Hyhorin
LMST02010043
LS-187148
LS-64886
MFCD00070035
MLS000069757
MLS001424259
MolPort-005-940-816
Morestin
NC00413
NCGC00179418-01
NSC 18313
NSC-18313
NSC18313
oestrone sulphate
Oestrone-3-sulphate sodium salt
Ogen
Ogen (TN)
OGEN 2.5
Ortho-Est
Par Estro
potassium estrone 3-sulfate(1-)
potassium;[(8R,9S,13S,14S)-13-methyl-17-oxidanylidene-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] sulfate
potassium;[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] sulfate
potassium;[(8R,9S,13S,14S)-17-keto-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] sulfate
Premarin
Premarin tabs
Premarin Vaginal
Prempro/Premphase
Prestwick0_000688
Prestwick1_000688
Prestwick2_000688
Prestwick3_000688
QTL48N278K
SCHEMBL22846
SCHEMBL4616
SMR000058772
sodium (8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl sulfate
sodium [(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate
sodium 17-oxoestra-1(10),2,4-trien-3-yl sulfate
Sodium estrone 3-monosulfate
Sodium estrone 3-monosulphate
Sodium estrone 3-sulfate
Sodium estrone 3-sulphate
Sodium estrone sulfate
Sodium estrone-3-sulfate
SPBio_002736
UNII-3ASP8Q3768 component VUCAHVBMSFIGAI-ZFINNJDLSA-M
UNII-6K6FDA543A
UNII-8L6LAK9BTR component VUCAHVBMSFIGAI-ZFINNJDLSA-M
UNII-IU5QR144QX component VUCAHVBMSFIGAI-ZFINNJDLSA-M
UNII-JM2621P2LS component VUCAHVBMSFIGAI-ZFINNJDLSA-M
UNII-QTL48N278K
ZINC3876186

US Patents and Regulatory Information for EVEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche Palo EVEX estrogens, esterified TABLET;ORAL 084215-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Roche Palo EVEX estrogens, esterified TABLET;ORAL 083376-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Merck
Mallinckrodt
Moodys
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.